Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 May:89:578-582.e3.
doi: 10.1016/j.wneu.2015.11.061. Epub 2015 Dec 15.

Extraneural Glioblastoma Multiforme Vertebral Metastasis

Affiliations
Review

Extraneural Glioblastoma Multiforme Vertebral Metastasis

C Rory Goodwin et al. World Neurosurg. 2016 May.

Abstract

Glioblastoma multiforme (GBM) is the most common malignant central nervous system tumor; however, extraneural metastasis is uncommon. Of those that metastasize extraneurally, metastases to the vertebral bodies represent a significant proportion. We present a review of 28 cases from the published literature of GBM metastasis to the vertebra. The mean age at presentation was 38.4 years with an average overall survival of 26 months. Patients were either asymptomatic with metastasis discovered at autopsy or presented with varying degrees of pain, weakness of the extremities, or other neurologic deficits. Of the cases that included the time to spinal metastasis, the average time was 26.4 months with a reported survival of 10 months after diagnosis of vertebral metastasis. A significant number of patients had no treatments for their spinal metastasis, although the intracranial lesions were treated extensively with surgery and/or adjuvant therapy. With increasing incremental gains in the survival of patients with GBM, clinicians will encounter patients with extracranial metastasis. As such, this review presents timely information concerning the presentation and outcomes of patients with vertebral metastasis.

Keywords: Extracranial; Extraneural; Glioblastoma; Glioma; Metastasis; Spinal; Vertebral.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: C. Rory Goodwin, M.D., Ph.D., is a UNCF Merck Postdoctoral Fellow and has received an award from the Burroughs Wellcome Fund. Daniel M. Sciubba, M.D., is a consultant for Medtronic. This article reflects the views of the authors and should not be construed to represent the FDA’s views or policies.

Figures

Figure 1
Figure 1
Graph depicting frequency of bone metastasis from glioblastoma multiforme (GBM) based on Pasquier et al.’s series of extracranial metastasis of GBM.
Figure 2
Figure 2
Survival of patients diagnosed with a glioblastoma multiforme (GBM) spinal metastasis from (A) primary GBM diagnosis and (B) diagnosis of GBM spinal metastasis.

References

    1. Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro Oncol. 2014;16(suppl 4):iv1–iv63. - PMC - PubMed
    1. Lun M, Lok E, Gautam S, Wu E, Wong ET. The natural history of extracranial metastasis from glioblastoma multiforme. J Neurooncol. 2011;105:261–273. - PubMed
    1. Ray A, Manjila S, Hdeib AM, Radhakrishnan A, Nock CJ, Cohen ML, et al. Extracranial metastasis of gliobastoma: three illustrative cases and current review of the molecular pathology and management strategies. Mol Clin Oncol. 2015;3:479–486. - PMC - PubMed
    1. Elena A, Melina C, Raffaele N, Carlo B, Vittoria N, Francesco A, et al. Extraneural metastases in glioblastoma patients: two cases with YKL-40-positive glioblastomas and a meta-analysis of the literature. Neurosurg Rev. 2016;39:37–46. - PubMed
    1. Khattab MH, Marciscano AE, Lo SS, Lim M, Laterra JJ, Kleinberg LR, et al. Antiangiogenic therapies and extracranial metastasis in glioblastoma: a case report and review of the literature. Case Rep Oncol Med. 2015;2015:431819. - PMC - PubMed